Accessibility Menu
 
Emyria logo

Emyria

(ASX) EMD

Current Price$0.05
Market Cap$40.33M
Since IPO (2020)-65%
5 Year-77%
1 Year+67%
1 Month+0%

Emyria Financials at a Glance

Market Cap

$40.33M

Revenue (TTM)

$3.95M

Net Income (TTM)

$6.18M

EPS (TTM)

$-0.01

P/E Ratio

-6.10

Dividend

$0.00

Beta (Volatility)

-0.18 (Low)

Price

$0.05

Volume

3,388,341

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.02 - $0.08

EMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Emyria

Industry

Pharmaceuticals

CEO

Michael Winlo, MD, MBA

Website

emyria.com

Headquarters

Leederville, WA 6007, AU

EMD Financials

Key Financial Metrics (TTM)

Gross Margin

-57%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-59%

Return on Capital

-32%

Return on Assets

-33%

Earnings Yield

-16.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$40.33M

Shares Outstanding

806.56M

Volume

3.39M

Avg. Volume

2.28M

Financials (TTM)

Gross Profit

$24.48K

Operating Income

$2.65M

EBITDA

$2.39M

Operating Cash Flow

$2.70M

Capital Expenditure

$13.89K

Free Cash Flow

$2.72M

Cash & ST Invst.

$3.57M

Total Debt

$613.50K

Emyria Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.44M

+32.1%

Gross Profit

$1.33M

+16.6%

Gross Margin

-92.22%

N/A

Market Cap

$40.33M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$2.37M

+78.0%

EBITDA

$2.29M

+82.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$9.44M

+1046.4%

Accounts Receivable

$249.55K

+364.1%

Inventory

$0.00

N/A

Long Term Debt

$1.00M

+34.1%

Short Term Debt

$55.30K

-97.5%

Return on Assets

-33.31%

N/A

Return on Invested Capital

-32.07%

N/A

Free Cash Flow

$2.09M

+53.7%

Operating Cash Flow

$2.04M

+54.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MAP.AXMicroba Life Sciences Limited
$0.08+8.57%
NXS.AXNext Science Limited
$0.14+0.00%
IIQ.AXINOVIQ Ltd
$0.33+0.00%
EYE.AXNova Eye Medical Limited
$0.13-3.85%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.05+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.68+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.33+0.03%
NIONio
$5.92-0.07%

Questions About EMD

What is the current price of Emyria?

Emyria is trading at A$0.05 per share.

What is the 52-week range for Emyria?

Over the past 52 weeks, Emyria has traded between A$0.02 and A$0.08.

How much debt does Emyria have?

As of the most recent reporting period, Emyria reported total debt of $613,499.

How much cash does Emyria have on hand?

Emyria reported $3.57M in cash and cash equivalents in its most recent financial results.

What is Emyria’s dividend yield?

Emyria does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.